Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

The “Big Three” PBMs are kicking their suit up to the 8th Circuit and, in the meantime, are once again asking a Missouri district judge to halt the FTC’s administrative case against them.

11 News has reached out to Optum to learn more about their plans to close these locations. The following was sent to 11 News Evening Anchor Adam Atchison. “We regularly review products ...

According to reports, U.S. pharmacies are seeing major disruptions following a purported nation-state attack against Change Healthcare, a unit within UnitedHealth’s Optum subsidiary. A ...

Optum is the country’s largest employer of ... a bank that offers health-related financial products; and Change Healthcare, the technology firm that was recently subject to a cyberattack that ...